News and Comments

Elan's Choices

  Saturday, April 16, 2011

Biogen Idec (BIIB) announced positive results of a process aimed at Identifying high-risk patients for a life-threatening side effect of prolonged use of the multiple sclerosis drug Tysabri. This test is a necessity because it detects an antibody that points to the presence of the Polyomavirus JC (JC virus), which causes the life-threatening progressive multifocal leukoencephalopathy (PML). This side effect in one per thousand patients has deprived Elan from billions of dollars in expected sales of Tysabri.  More...


Recent Postings


Archive


Tags

Ariad (ARIA) Galena (GALE) Array Pharmaceuticals (ARRY) Ionis (IONS) Multiple Myeloma Sanofi-Aventis (SAN) Bristol-Myers Squibb (BMY) Endometrial Cancer Intercept (ICPT) Roche (RHHBY) IDERA (IDRA) RenenxBio (RGNX) Abbott Laboratories (ABT) Roche (ROCHE) Alder Biopharmaceuticals (ALDR) Jazz Pharmaceuticals (JAZZ) Amgen (AMGN) KITE (KITE) JUNO (JUNO) OSI (OSIP) Auspex (ASPX) Zerenex HALOZYME (HALO) ARGOS (ARGS) C4 Therapeutics Xoma (XOMA) GlaxoSmithKline (GSK) Genentech Pluristem (PSTI) INNOVIVA (INVA) Exelixis (EXEL) Velcade (bortezomib) Herceptin PTC Therapeutics (PTCT) Theravance Bio Pharma (TBPH) ABBVIE (ABBV) NEKTAR (NKTR)) Sarepta (SRPT) VANDA (VNDA) AERIE PHARMACEUTICALS Theravance (THRX) Cytokinetics (CYTK) ARCA (ABIO) Vertex (VRTX) Revlimid (lenolidamide) Telaprevir Intrexon (XON) SERES THERAPEUTICS (MCRB) KERYX (KERX) Sequenom (SQNM) Benlysta (belimumab) Dynavax (DVAX) Sanofi (SNA) Spike Therapeutics (ONCE) Human Genome Sciences (HGSI) ISIS (ISIS) Human Longevity (HLI) Prosensa (RNA) Valeant Pharmaceuticals International (VRX) Anadys (ANDS) BIOMARIN (BMRN) Mirati Therapeutics (MRTX) Ziofpharm (ZIOP) Merck (MRK) GUARDIAN HEALTH Rapamune ImmunoGen (IMGN) Gilead (GILD) Micromet (MITI) Aimmune Therapeutics (AIMT) ADVENTRIX (ANX) Sanofi (SNY) Elan (ELN) SUNESIS PHARMACEUTICALS (SNSS) Biocryst (BCRX) Regeneron (REGN) Inovio (INO) ACADIA (ACAD) Biogen Idec (BIIB) galapagos (GLPG) Prolor Biotech (PBTH) Onyx (ONXX) Global Cell Therapeutics (GBT) Intermune (ITMN) Tysabri Agenus (AGEN Idenix (IDIX) Anacor (ANAC) Seattle Genetics (SGEN) Vitae Pharmaceuticals (VTAE) REGULUS (RGLS) Dendreon (DNDN) Sangamo (SGMO) SYNTA (SNTA) Trastuzumab-DM1 ZALTRAP™ AGOS (ARGS) CompuGen (CGEN) NANTKWEST (NK) Editas (EDIT) Alnylam (ALNY) Incyte (INCY) TOKAI (TKAOI) Illumina (ILMN) Ridaforolimus Agenus (AGEN)